MENU

ACHFF Stock Arch Biopartners (ACHFF, $1.19) was a top loser this week, declining -7.03%

A.I.dvisor
at Tickeron.com
Loading...
ACHFF - Arch Biopartners Inc.
Tickeron

Loading...

Price: $1.19
Daily change: -$0.015 (-1.24%)
Daily volume: 6.2K
Weekly price change: -$0.09 (-7.03%)
Capitalization: $78.7M
Industry: Biotechnology
Arch Biopartners (ACHFF, $1.19) was a top weekly loser, falling to $1.19 per share. Of the 809 stocks analyzed in the Biotechnology Industry throughout the week of July 7/23/2025 - 7/30/2025, 2025, of them (3) exhibited an Uptrend while of them (6) were in a Downtrend.

ACHFF saw its Stochastic Oscillator peaks and leaves the overbought zone

The Stochastic Oscillator for ACHFF moved out of overbought territory on August 15, 2025. This could be a bearish sign for the stock and investors may want to consider selling or taking a defensive position. A.I.dvisor looked at 53 similar instances where the indicator exited the overbought zone. In of the 53 cases the stock moved lower. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on August 15, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on ACHFF as a result. In of 96 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

ACHFF moved below its 50-day moving average on July 23, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for ACHFF crossed bearishly below the 50-day moving average on July 11, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 17 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ACHFF declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for ACHFF entered a downward trend on August 11, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for ACHFF just turned positive on August 04, 2025. Looking at past instances where ACHFF's MACD turned positive, the stock continued to rise in of 42 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ACHFF advanced for three days, in of 198 cases, the price rose further within the following month. The odds of a continued upward trend are .

ACHFF may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. ACHFF’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (19.528). P/E Ratio (0.000) is within average values for comparable stocks, (52.377). ACHFF's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.945). Dividend Yield (0.000) settles around the average of (0.042) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (294.394).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ACHFF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock better than average.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

View a ticker or compare two or three
ACHFF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
545 King Street West
Phone
+1 647 428-7031
Employees
N/A
Web
https://www.archbiopartners.com